Commentary
Anxiety over funding, targets as research landscape evolves
Scientists looking wistfully back seven years call the period the golden age of Singapore's biomedical industry.
Research funds flowed freely, superstar scientists moved here from across the world, and the gleaming Biopolis research hub stood as the crown jewel of the Republic's research ambitions. Institutes were running at full throttle, papers were being churned out, start-ups were emerging.
TO READ THE FULL ARTICLE
Thank you for reading The Straits Times
You have reached one of our Premium stories. To continue reading, get access now or log in if you are a subscriber.
What is Premium?